Recurrent sebaceous carcinoma of the eyelid: Outcome after postoperative reirradiation

Head Neck. 2016 Jan;38(1):E16-9. doi: 10.1002/hed.24089. Epub 2015 Jul 18.

Abstract

Background: The purpose of this study was for us to describe a case of recurrent sebaceous carcinoma treated with postoperative reirradiation.

Methods: A 38-year-old man was diagnosed with sebaceous carcinoma of the right lower eyelid. The patient developed local recurrence 4 times, with the first one at 30 months after the excision. The first local recurrence was treated with excision and postoperative radiotherapy with 60 Gy/30 fractions/6 weeks. He manifested preauricular nodal metastasis with the third local recurrence, which was confirmed with (18)F-fluorodeoxyglucose positron emission tomography-CT ((18)F-FDG PET-CT). He received 2 courses of adjuvant reirradiation to the right orbit with 45 Gy/25 fractions/5 weeks and 30 Gy/15 fractions/3 weeks, respectively.

Results: The patient was successfully treated with no evidence of locoregional recurrence at 2 years after the cancer-directed therapy. The patient's follow-up from the date of diagnosis has been 9 years.

Conclusion: Adjuvant reirradiation with modest doses may be considered with a view to provide disease control and long-term survival.

Keywords: adjuvant radiotherapy; eyelids; recurrence; reirradiation; sebaceous gland neoplasms.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Sebaceous / secondary*
  • Adenocarcinoma, Sebaceous / therapy*
  • Adult
  • Blepharoplasty* / methods
  • Eyelid Neoplasms / pathology*
  • Eyelid Neoplasms / therapy*
  • Facial Neoplasms / secondary
  • Facial Neoplasms / therapy
  • Humans
  • Male
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / therapy*
  • Positron-Emission Tomography / methods
  • Postoperative Period
  • Radiopharmaceuticals / pharmacology
  • Radiotherapy, Adjuvant* / methods
  • Re-Irradiation
  • Reoperation
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Radiopharmaceuticals